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ABSTRACT
OBJECTIVE: To evaluate the performance of post mortem laboratory analysis in identifying 
the causes of hemorrhagic fever and/or neuroinvasive disease in deaths by arbovirus infection. 
METHODS: Retrospective cross-sectional study based on the differential analysis and final 
outcome obtained in patients whose samples underwent laboratory testing for arboviruses at 
the Pathology Center of the Adolfo Lutz Institute, in São Paulo, Brazil. 
RESULTS: Of the 1355 adults clinically diagnosed with hemorrhagic fever and/or neuroinvasive 
disease, the most commonly attributed cause of death and the most common final outcome 
was dengue fever. Almost half of the samples tested negative on all laboratory tests conducted. 
CONCLUSION: The failure to identify the causative agent in a great number of cases highlights 
a gap in the diagnosis of deaths of unknown etiology. Additional immunohistochemical 
and molecular assessments need to be added to the post-mortem protocol if all laboratory 
evaluations performed fail to identify a causative agent. While part of our findings may be due 
to technical issues related to sample fixation, better information availability when making 
the initial diagnosis is crucial. Including molecular approaches might lead to a significant 
advancement in diagnostic accuracy.
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INTRODUCTION
The Brazilian National Health System (SUS) surveillance system is responsible for 
investigating causes of death related to infectious diseases in the state of São Paulo1. 
When a diagnosis of the cause of death is uncertain, the system performs a post-mortem 
analysis encompassing all available clinical, laboratory and epidemiological evidence to 
assess possible etiological agents. This represents the final opportunity to establish the 
most likely diagnosis and subsequently alert public health officials to initiate improved 
surveillance measures.  
Arboviruses (ARthropod-BOrne virus) are responsible for a large number of different 
infections with similar clinical manifestations, ranging from mild to severe febrile illnesses, 
hemorrhagic fever, and neuroinvasive diseases2. Several outbreaks have occurred in Brazil 
due to newly introduced or re-emerging arboviruses3,4, each representing a serious public 
health issue due to difficulties in containment, differential diagnosis and treatment. When 
caused by non-Arbovirus diseases, laboratory analysis play a pivotal role in the differential 
diagnosis of hemorrhagic fever (leptospirosis, spotted fever, hantavirus5) and neuroinvasive 
diseases (such as meningitis, herpes, rabies6).
This study evaluates the performance of post-mortem laboratory analysis in identifying 
the causes of deaths associated with hemorrhagic fever and/or neuroinvasive disease of 
unknown etiology in the state of São Paulo from 2009 to 2019.
METHODS
Study Design
This is a retrospective cross-sectional study conducted at the Pathology Center of the Adolfo 
Lutz Institute between January 2009 and February 2019. Patient records and laboratory 
results were accessed in the laboratory management systems (GAL and SIGH).
Referral Pathway
According to recommendations from the Ministry of Health, all suspected deaths must 
be investigated following the São Paulo State Protocol for the Investigation of Severe 
Cases and Deaths by Urban Arbovirus1, in which samples follow a designated laboratory 
flow chart (Figure 1). For the purpose of this study, we grouped the cases according to 
their initial proposed diagnosis, which was based on clinical, laboratory, epidemiological, 
and necroscopic information – typical basis for post-mortem laboratory analysis. After a 
multi-organ histopathological analysis, a second possible diagnosis may become evident, 
which then required further assessment of the immunohistochemistry findings (Figure 1).
Inclusion Criteria  
Our study included patients whose samples underwent laboratory testing for any arbovirus, 
based on suspected cause of death. Samples were referred for laboratory confirmation if 
they were related to: 
• an urban arbovirus infection outbreak by clinical (regardless of disease progression or 
the duration of its acute phase) and epidemiological evidence7.  
• presumed non-arbovirus pathogens, not confirmed by laboratory testing, in which 
multi-organ histopathological analysis showed findings suggestive of arbovirus infection.
Clinical Samples and Laboratory Assays
For real-time PCR (qPCR), blood and multi-organ samples (Table 1) were collected during 
the necroscopic examination, immediately frozen, and sent to the Adolfo Lutz Institute. 
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Multi-organ tissue fragments (Table 1) were also formalin-fixed, paraffin-embedded (FFPE)1, 
and subjected to histopathological assessment and complementary immunohistochemistry. 
Assays for chikungunya (Evandro Chagas Institute, Para, Brazil), influenza A/H1N1 virus 
(FluA/H1N1v) (CDC, Atlanta, USA) and Neisseria meningitidis (Adolfo Lutz Institute; São 
Paulo, Brazil) were performed following the standard operating procedures from the 
Laboratory of Anatomical Pathology of the Adolfo Lutz Institute. Table 1 presents a time 
lapse of the methods used in the study according to the pathogen and sample analyzed. 
Patients with clinical diagnosis of acute hemorrhagic fever syndrome (AHFS) were tested for 
dengue, yellow fever, leptospirosis, hantavirus and rickettsiosis (if there was epidemiological 
evidence), N. meningitidis (if meningitis was suspected by the physician). Patients with 
clinical diagnosis of severe acute respiratory syndrome (SARS) were tested for FluA/H1N1v. 
Statistical Analysis
Geographic characterization of the post-mortem cases was performed using the Quantum 
GIS v. 3.8.3 software; frequency and statistical analysis were performed using Excel (mean 
and standard deviation [SD]). 
Ethics Statement
This study involved the analysis of routinely collected surveillance data, thus dispensing 
an Informed Consent Form, according to the Brazilian National Committee for Research 
Ethics. All procedures were approved by the Adolfo Lutz Institute’s Research Ethics 
Committee (CAAEE 96138818.0.0000.0059). 
Figure 1. Flow chart for the investigation of post mortem cases related to urban arboviruses at the Adolfo Lutz Institute.
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RESULTS
From the initial 1405 cases, we excluded those involving stillbirths and children under 
one, resulting in 1355 cases for analysis. Most cases (847, 62%) involved males, with a 
median (range) age of 40 (26–55) years. 
Table 1. Laboratory methods applied to the surveillance of deaths with suspected arbovirus infection.


















Immunohistochemistryb Heart, lungs, muscle  
Zika vírus 2016–2018
Immunohistochemistryb Brain, placenta, fetal tissue
qPCR11 Brain, placenta, fetal tissue and blood




































qPCR16 Liver, spleen, skin
a Polyclonal primary antibodies and polymer conjugated secondary antibodies.
b Monoclonal primary antibodies and polymer conjugated secondary antibodies.
c CDC/Atlanta/EUA.
Table 2. Most common diagnostic hypotheses related to patient deaths associated with hemorrhagic 
fever and/or neuroinvasive disease of unknown etiology in the state of São Paulo from 2009 to 2019.
Initial diagnosis




Yellow fever 398 (29)




Zika virus 23 (2)
a Percentages from the 1355 cases included in the dataset. Most cases received more than one differential 
diagnosis, resulting in the percentages totaling more than 100%. 
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Table 2 shows the most common diagnostic hypotheses related to the cause of death in 
these patients. Most samples were tested for dengue (76%), followed by leptospirosis (47%), 
yellow fever (29%), rickettsia (28%), hantavirus (24%), influenza (16%), chikungunya (4%) 
and zika virus (2%), with immunohistochemistry being the most frequently employed 
detection method (Table 3). 
Table 3. Number of cases tested for each etiologic agent and the testing methods employed for diagnosing 
patient deaths associated with hemorrhagic fever and/or neuroinvasive disease of unknown etiology in 






IHC and/or PCRa, 
n (%)
Dengue 1,034 (76) 494 (36) 1,130 (83)
Leptospira spp. 905 (67) 25 (2) 912 (67)
Yellow fever 517 (38) 303 (22) 562 (41)
Rickettsia 697 (51) 2 (< 1) 698 (51)
Hantavirus 361 (27) 162 (12) 413 (30)
Influenza 113 (8) 61 (5) 152 (11)
Chikungunya 24 (2) 51 (4) 62 (5)
Zika virus 11 (1) 30 (2) 35 (3)
a Some cases underwent both tests. Percentages from the 1355 cases (full dataset). IHC – immunohistochemistry; 
qPCR – real-time polymerase chain reaction.
Table 4. Set of differential diagnostic tests according to the initial diagnosis of patient deaths associated with hemorrhagic fever and/or 
neuroinvasive disease of unknown etiology in the state of São Paulo from 2009 to 2019.
Initial Diagnosis (n)













Dengue, (1034) 968 (94) 730 (71) 334 (32) 555 (54) 352 (34) 112 (11) 46 (4) 21 (2)
Leptospirosis, (633) 572 (90) 606 (96) 258 (41) 415 (66) 262 (41) 79 (12) 32 (5) 9 (1)
Yellow fever, (398) 250 (63) 249 (63) 374 (94) 228 (57) 154 (39) 37 (9) 37 (9) 16 (4)
Rickettsia, (382) 348 (91) 342 (90) 194 (51) 349 (91) 193 (51) 34 (9) 29 (8) 5 (1)
Hantavirus, (319) 300 (94) 265 (83) 155 (49) 218 (68) 283 (89) 66 (21) 15 (5) 3 (1)
Influenza, (212) 118 (56) 134 (63) 58 (27) 102 (48) 96 (45) 90 (42) 14 (7) 4 (2)
Chikungunya, (48) 38 (79) 33 (69) 33 (69) 32 (67) 20 (46) 8 (17) 26 (54) 10 (21)
Zika virus, (23) 15 (65) 8 (35) 9 (39) 16 (70) 4 (17) 2 (9) 10 (43) 16 (70)
Note: Percentages are out of the total in column 1 – e.g., 94% of cases in which dengue were the initial diagnoses were tested for dengue.
Table 5. Final outcomes of patient deaths associated with hemorrhagic fever and/or neuroinvasive 





Leptospira spp. 78 (6)





Zika virus 3 (< 1)
Other infectious diseasea 139 (10)
Other non-infectious diseaseb 20 (1)
No final diagnosis 649 (48)
a Sepsis, gram-positive/negative bacterial infection, lung inflammation/infection, viral hepatitis, fungal infection, 
adenovirus, enterovirus, herpes, rubeola, schistosomiasis and varicella. 
b Disseminated intravascular coagulation, neoplasm, hepatopathy, heart attack.
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Table 4 presents the set of differential diagnostic tests employed. Even the high number 
of tests performed in these sets was insufficient to elucidate most cases, since almost half 
(48%) tested negative in all laboratory tests conducted, having to rely only on clinical and 
epidemiological findings for a resolution. Among those with a definitive final diagnosis, 
145 (11%) tested positive for dengue, 140 (10%) for yellow fever, 89 (7%) for influenza and 
79 (6%) for rickettsia (Table 5). Figure 2 shows the variation between the number of cases 
according to initial and final diagnosis, depicting the increase in the number of suspected 
and confirmed cases in specific years, as occurred for dengue, yellow fever and rickettsia 
outbreaks. The annual seasonal pattern of influenza outbreaks is also evident. 
Green line – number of deaths linked to a given differential diagnosis. Blue line – number of cases that received 
that final diagnosis (e.g., from the top left panel is the number of cases that received a final dengue diagnosis). In 
the “All ddx” panel (bottom left) the black line refers to all cases of suspected arboviral infection (whole dataset) 
and the blue line those cases that received a final diagnosis. The temporal aggregation is on a seasonal level.
Figure 2. Variation in the number of cases according to the most common initial diagnosis and 
corresponding final diagnosis of deaths associated with hemorrhagic fever and/or neuroinvasive of 
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DISCUSSION
Our findings based on the analysis of postmortem data from 1355 adults diagnosed with 
clinical syndromes suggesting arbovirus infection between 2009 and 2019 revealed that 
almost half of the cases did not reach a final diagnosis of the causative agent. This highlights 
the existence of a serious gap in the epidemiological surveillance of endemic and emerging 
infections in Brazil. 
The set of diagnostic tests employed as part of the post-mortem protocol may therefore 
require additional immunohistochemical and/or molecular evaluation if all laboratory 
results fail to identify a causative agent. As a result of the post-mortem investigation, 
about 10% of the final diagnoses differed from the initial diagnoses. Diseases such as 
bacterial/fungal infection, viral hepatitis, adenovirus, enterovirus, herpes, neoplasms, and 
heart attacks would have remained undiagnosed if it were not for the histopathological 
post-mortem investigation procedures. Moreover, the set of diagnostic tests performed on 
fresh tissue is different from that performed on FFPE tissue. Ideally, both tissue specimens 
would be collected17, but sometimes only one of them is available. In our cohort, some of 
the FFPE samples lacked a corresponding fresh aliquot available and therefore relied only 
on immunohistochemical and anatomopathological analysis for diagnosis. 
We also have a clear logistics limitation depending on the distance from the collection 
point to the reference center, along with transport conditions. Although the qPCR assay 
is able to provide information on the presence of infectious agents at the molecular level, 
being a very high specific analysis18, it is performed only on fresh frozen tissue in public 
surveillance laboratories. Despite its technical limitations19,20, FFPE analysis provides 
valuable support to immunohistochemical21,22 and anatomopathological evidence. 
Cytological architecture is preserved and the samples can be used to perform molecular 
tests, such as conventional23 or quantitative reverse transcriptase PCR19,20. It is important 
to consider, however, that although immunohistochemistry may reveal the presence 
of viral antigens within the tissue sample, its specificity may be limited due to the 
cross-reactivity observed in commercially available antibodies20,24–26 This reinforces the 
need to use molecular methods as a complementary tool for FFPE. 
Despite all efforts to identify an etiological agent, almost half of the cases investigated at 
the Pathology Center during the study did not receive a final laboratory diagnosis, thus 
relying solely on clinical and epidemiological information for a tentative conclusion1. 
This is consistent with prior studies reporting that conventional laboratory assays failed 
to detect a causative agent in approximately 40% of gastroenteritis27 cases and 60% of 
encephalitis28 cases. Part of our findings could be attributed to technical issues related 
to sample fixation20–21, but we also highlight the importance of better information 
availability when making the initial diagnosis, and having these data available to the 
reference laboratories (via online laboratory management systems). Lack of clinical 
data may limit implementing additional laboratory approaches. The more complete and 
accurate the investigation, the better will be the quality of laboratory surveillance, not 
only reducing the waiting time for a result, but also limiting the number of unnecessary 
tests and consequently easing the financial burden on Public Health. 
As identified, many other common non-infectious diseases/pathologies (e.g., neoplasms, 
hepatopathies, vasculitis, hematologic diseases) can mimic arbovirus infections and even 
hemorrhagic fevers, misleading the diagnostic hypothesis. Another point to consider is 
that even when laboratory reports are negative for all tested pathogens, the undetected 
causative agent may be a known species that was simply not included in the laboratory’s 
testing algorithm. Alternatively, it might involve a truly novel pathogen29. Surveillance 
laboratories must be constantly prepared to identify new pathogens, because their rapid 
detection is necessary to initiate public health measures. 
A potential way to improve laboratory surveillance would be to perform PCR on FFPE 
samples30,31, using specific kits or protocols. Pathogen non-specific molecular methods, such 
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as metagenomic approaches, could have even greater efficacy. Metagenomic sequencing 
can be used to detect any pathogen without the need for sequence-specific amplification. 
These sequence data can then be used to predict antibiotic resistance phenotypes32, 
detect co-infections33,  identify infectious disease outbreaks of unknown causes, and 
diagnose patients with suspected infections but negative results in conventional tests34. 
This could be a powerful new tool for post-mortem analysis for surveillance purposes. 
As next-generation sequencing technologies continue to improve and its costs reduced, 
metagenomic approaches may become increasingly common in public health laboratories. 
Depending on the clinical and epidemiological information available, a syndromic laboratory 
approach could be useful for diagnosing hemorrhagic fever deaths of unknown etiology. 
Multiplex molecular diagnostic assays are able to simultaneously detect and identify the 
most frequent infectious causes of a single clinical syndrome. They are more accurate, faster 
and convenient than most techniques previously used in the laboratory35,36.
Thus, using a syndromic panel applied to hemorrhagic fever deaths of unknown etiology 
could contribute to improved surveillance, as has been shown in the diagnosis of respiratory, 
gastrointestinal, and central nervous system infections35,36. Monitoring spatial-temporal 
trends to identify clusters of negative cases can be used to facilitate early detection of silent 
infectious disease outbreaks37 or even overcome logistical issues affecting sample quality 
and results, which can occur in non-random yet clustered distributions. 
Importantly, the SARS-CoV-2 virus, cause of the COVID-19 acute respiratory disease, was 
detected in Wuhan, China, by monitoring the emergence of severe cases of “pneumonia 
of unknown etiology”38,39. This underlines the importance of surveillance systems for fatal 
infectious diseases of unknown etiology to help recognize the emergence of a new outbreak.
CONCLUSION
Our findings highlight the relevance of a post-mortem laboratory investigation for the 
accurate diagnosis of arbovirus infections, revealing a gap in the surveillance of deaths from 
hemorrhagic fever and/or neuroinvasive disease caused by arbovirus infection in the state 
of São Paulo. The availability of more comprehensive patient data to reference laboratories 
could improve the quality of laboratory testing. In the future, metagenomic and syndromic 
laboratory approaches might lead to a significant advance in diagnostic accuracy, thus 
directly contributing to solving these death causes.
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